BridgeMD
New treatment option for Gender Dysphoria
Official title Patient Reported Outcome on Genital Sensitivity and Sexual Function After Genital Gender Affirming Surgery
ClinicalTrials.gov ID: NCT04993469
What this study is testing
- What it's testing
- For genital gender affirming surgery, it remains unclear to what extent genital sensitivity might be expected and what the impact of this might be on sexual functioning.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 110
You may be able to join if
- Voluntarily signed written informed consent according to the rules of Good Clinical Practice (Declaration of Helsinki) and national regulations
- Patient age ≥ 18 years
- Transgender male, female of gender non-conforming patient with diagnosed gender dysphoria and the specific wish to undergo genital gender affirming...
- Fit for operation, based on the surgeon's expert opinion
- Patient is able and willing to attend the follow-up consultations
You likely can't join if
- Absence of signed written informed consent and thus a patient unwilling to participate.
- Patient age \< 18 years
- Cisgender patients
- Patients unfit for operation
- Patient declares that it will be impossible for him to attend the follow-up consultations
The study team makes the final eligibility decision.
Where it's taking place
- Ghent, East-Flanders, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 110 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ghent, East-Flanders, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.